MRI of carriers of the apolipoprotein E e4 allele-evidence for structural differences in normal-appearing brain tissue in e4+ relative to e4- young adults

NMR in Biomedicine

Volumn 26, Issue 6, 2013, Pages 674-682

  Dowell, Nicholas G ^b   Ruest, Torsten ^a   Evans, Simon L ^a   King, Sarah L ^a   Tabet, Naji ^b   Tofts, Paul S ^b   Rusted, Jennifer M ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Apolipoprotein E e4; Cognition; Diffusion tensor imaging; Neural efficiency; Quantitative magnetisation transfer; Tract based spatial statistics; Voxel based morphometry

Indexed keywords

APOLIPOPROTEIN E; COGNITION; NEURAL EFFICIENCIES; QUANTITATIVE MAGNETISATION TRANSFER; SPATIAL STATISTICS; VOXEL-BASED MORPHOMETRY;

BRAIN; DIFFUSION TENSOR IMAGING; DNA SEQUENCES; LIPOPROTEINS; MAGNETIC RESONANCE IMAGING; MAGNETIZATION; TENSORS;

GENES;

APOLIPOPROTEIN E4;

ADULT; ALLELE; ANISOTROPY; ARTICLE; BRAIN SIZE; BRAIN TISSUE; CLINICAL TRIAL; COGNITION; FEMALE; GENOTYPE; HOMOZYGOTE; HUMAN; IMAGE PROCESSING; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ADULT; ALLELES; APOLIPOPROTEIN E4; BRAIN; COGNITION; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; MALE; YOUNG ADULT;

EID: 84876792760     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2912     Document Type: Article

References (81)

1. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009; 10(5): 333-344.
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240(4852): 622-630.
3. Hatters DM, Peters-Libeu CA, Weisgraber KH. Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 2006; 31(8): 445-454.
4. Mathew C. Science, medicine, and the future: postgenomic technologies: hunting the genes for common disorders. Brit. Med. J. 2001; 322(7293): 1031-1034.
5. Small BJ, Rosnick CB, Fratiglioni L, Backman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol. Aging 2004; 19(4): 592-600.
6. Wisdom NM, Callahan JL, Hawkins KA. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol. Aging 2011; 32(1): 63-74.
7. Mondadori CR, de Quervain DJ, Buchmann A, Mustovic H, Wollmer MA, Schmidt CF, Boesiger P, Hock C, Nitsch RM, Papassotiropoulos A, Henke K. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb. Cortex 2007; 17(8): 1934-1947.
8. Wright RO, Hu H, Silverman EK, Tsaih SW, Schwartz J, Bellinger D, Palazuelos E, Weiss ST, Hernandez-Avila M. Apolipoprotein E genotype predicts 24-month Bayley scales infant development score. Pediatr. Res. 2003; 54(6): 819-825.
9. Yu CS, Lin FC, Zhao L, Ye J, Qin W. Occult white matter damage contributes to intellectual disability in tuberous sclerosis complex. Intelligence, 2009; 37(2): 174-180.
10. Hubacek JA, Pitha J, Skodova Z, Adamkova V, Lanska V, Poledne R. A possible role of apolipoprotein E polymorphism in predisposition to higher education. Neuropsychobiology 2001; 43(3): 200-203.
11. Alexander DM, Williams LM, Gatt JM, Dobson-Stone C, Kuan SA, Todd EG, Schofield PR, Cooper NJ, Gordon E. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biol. Psychol. 2007; 75(3): 229-238.
12. Marchant NL, King SL, Tabet N, Rusted JM. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacol. 2010; 35(5): 1090-1096.
13. Rusted J, King SL, Dowell NG, Tofts P, Tabet N, Evans S. APOE e4 polymorphism in young adults is associated with improved attention and indexed by distinct neural signatures. NeuroImage, 2012; 65: 364-373.
14. Ruiz JR, Castillo R, Labayen I, Moreno LA, Fuentes MG, Lamuno DG, Alvarez Granda JL, Lucia A, Ortega FB. Individual and combined effects of ApoE and MTHFR 677C/T polymorphisms on cognitive performance in Spanish adolescents: the AVENA study. J. Pediatr. 2010; 156(6): 978-984, 984 e971.
15. Turic D, Fisher PJ, Plomin R, Owen MJ. No association between apolipoprotein E polymorphisms and general cognitive ability in children. Neurosci. Lett. 2001; 299(1-2): 97-100.
16. Ihle A, Bunce D, Kliegel M. APOE epsilon4 and cognitive function in early life: a meta-analysis. Neuropsychology, 2012; 26(3): 267-277.
17. Evans S, Gray MA, Dowell NG, Tabet N, Tofts P, King SL, Rusted J. APOE E4 carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10. Neuropsychopharmacol. 2012. doi: 10.1038/npp.2012.230. [Epub ahead of print]
18. Han SD, Bondi MW. Revision of the apolipoprotein E compensatory mechanism recruitment hypothesis. Alzheimers Dement. 2008; 4(4): 251-254.
19. Zetterberg H, Alexander DM, Spandidos DA, Blennow K. Additional evidence for antagonistic pleiotropic effects of APOE. Alzheimers Dement. 2009; 5(1): 75.
20. Kennedy KM, Raz N. Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 2009; 47(3): 916-927.
21. Madden DJ, Whiting WL, Huettel SA, White LE, MacFall JR, Provenzale JM. Diffusion tensor imaging of adult age differences in cerebral white matter: relation to response time. NeuroImage 2004; 21(3): 1174-1181.
22. Salthouse TA. Neuroanatomical substrates of age-related cognitive decline. Psychol. Bull. 2011; 137(5): 753-784.
23. Madden DJ, Bennett IJ, Burzynska A, Potter GG, Chen NK, Song AW. Diffusion tensor imaging of cerebral white matter integrity in cognitive aging. Biochim. Biophys. Acta 2012; 1822(3): 386-400.
24. Deary IJ, Bastin ME, Pattie A, Clayden JD, Whalley LJ, Starr JM, Wardlaw JM. White matter integrity and cognition in childhood and old age. Neurology 2006; 66(4): 505-512.
25. Ridha BH, Symms MR, Tozer DJ, Stockton KC, Frost C, Siddique MM, Lewis EB, MacManus DG, Boulby PA, Barker GJ, Rossor MN, Fox NC, Tofts PS. Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. Am. J. Neuroradiol. 2007; 28(5): 965-970.
26. Vrenken H, Pouwels PJW, Ropele S, Knol DL, Geurts JJG, Polman CH, Barkhof F, Castelijns JA. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Mult. Scler. 2007; 13(6): 708-716.
27. Kiefer C, Brockhaus L, Cattapan-Ludewig K, Ballinari P, Burren Y, Schroth G, Wiest R. Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: the impact of quantitative magnetization transfer MR imaging. NeuroImage 2009; 48(4): 657-667.
28. Giulietti G, Bozzali M, Figura V, Spano B, Perri R, Marra C, Lacidogna G, Giubilei F, Caltagirone C, Cercignani M. Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains. NeuroImage 2012; 59(2): 1114-1122.
29. Davies GR, Tozer DJ, Cercignani M, Ramani A, Dalton CM, Thompson AJ, Barker GJ, Tofts PS, Miller DH. Estimation of the macromolecular proton fraction and bound pool T2 in multiple sclerosis. Mult. Scler. 2004; 10(6): 607-613.
30. Tozer DJ, Davies GR, Altmann DR, Miller DH, Tofts PS. Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magnet. Reson. Med. 2005; 53(6): 1415-1422.
31. Schmierer K, Tozer DJ, Scaravilli F, Altmann DR, Barker GJ, Tofts PS, Miller DH. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain. J Magn. Reson. Imaging 2007; 26(1): 41-51.
32. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11(4): 575-580.
33. Marchant NL, King SL, Tabet N, Rusted JM. Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers. Neuropsychopharmacol. 2010; 35(5): 1090-1096.
34. Nelson HE. The National Adult Reading Test (NART): Test Manual. NFER-Nelson: Windsor, Berkshire; 1982.
35. Rusted JM, Warburton DM. Effects of scopolamine on verbal memory; a retrieval or acquisition deficit? Neuropsychobiology 1989; 21(2): 76-83.
36. Lezak MD. Neuropsychological Assessment. Oxford University Press: New York, NY; 1995.
37. Cercignani M, Symms MR, Schmierer K, Boulby PA, Tozer DJ, Ron M, Tofts PS, Barker GJ. Three-dimensional quantitative magnetisation transfer imaging of the human brain. NeuroImage 2005; 27(2): 436-441.
38. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. NeuroImage 2000; 11(6 Pt 1): 805-821.
39. Ashburner J, Friston KJ. Unified segmentation. NeuroImage 2005; 26(3): 839-851.
40. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 2002; 15(1): 273-289.
41. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 2001; 14(1 Pt 1): 21-36.
42. Mueller SG, Laxer KD, Cashdollar N, Buckley S, Paul C, Weiner MW. Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia 2006; 47(5): 900-907.
43. Radua J, Via E, Catani M, Mataix-Cols D. Voxel-based meta-analysis of regional white-matter volume differences in autism spectrum disorder versus healthy controls. Psychol. Med. 2011; 41(7): 1539-1550.
44. White NS, Alkire MT, Haier RJ. A voxel-based morphometric study of nondemented adults with Down Syndrome. NeuroImage 2003; 20(1): 393-403.
45. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004; 23 Suppl 1: S208-S219.
46. Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T, Beckmann C, Jenkinson M, Smith SM. Bayesian analysis of neuroimaging data in FSL. NeuroImage 2009; 45(1 Suppl): S173-S186.
47. Ennis DB, Kindlmann G. Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magnet. Reson. Med. 2006; 55(1): 136-146.
48. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TEJ. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 2006; 31(4): 1487-1505.
49. Cercignani M, Symms MR, Schmierer K, Boulby PA, Tozer DJ, Ron M, Tofts PS, Barker GJ. Three-dimensional quantitative magnetisation transfer imaging of the human brain. NeuroImage 2005; 27(2): 436-441.
50. Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, Bronskill MJ. Quantitative interpretation of magnetization transfer. Magnet. Reson. Med. 1993; 29(6): 759-766.
51. Ramani A, Dalton C, Miller DH, Tofts PS, Barker GJ. Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. Magn. Reson. Imaging 2002; 20(10): 721-731.
52. Tozer D, Ramani A, Barker GJ, Davies GR, Miller DH, Tofts PS. Quantitative magnetization transfer mapping of bound protons in multiple sclerosis. Magnet. Reson. Med. 2003; 50(1): 83-91.
53. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001; 5(2): 143-156.
54. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 2002; 15(1): 1-25.
55. Eickhoff SB, Paus T, Caspers S, Grosbras MH, Evans AC, Zilles K, Amunts K. Assignment of functional activations to probabilistic cytoarchitectonic areas revisited. NeuroImage 2007; 36(3): 511-521.
56. Eickhoff SB, Heim S, Zilles K, Amunts K. Testing anatomically specified hypotheses in functional imaging using cytoarchitectonic maps. NeuroImage 2006; 32(2): 570-582.
57. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. NeuroImage 2005; 25(4): 1325-1335.
58. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE. Distinct patterns of brain activity in young carriers of the APOE-epsilon 4 allele. Proc. Natl. Acad. Sci. USA 2009; 106(17): 7209-7214.
59. Miller EM. Intelligence and brain myelination - a hypothesis. Pers. Indiv. Differ. 1994; 17(6): 803-832.
60. Neubauer AC, Fink A. Intelligence and neural efficiency. Neurosci. Biobehav. Rev. 2009; 33(7): 1004-1023.
61. Shaw P, Lerch JP, Pruessner JC, Taylor KN, Rose AB, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol. 2007; 6(6): 494-500.
62. Dennis NA, Browndyke JN, Stokes J, Need A, Burke JR, Welsh-Bohmer KA, Cabeza R Temporal lobe functional activity and connectivity in young adult APOE epsilon4 carriers. Alzheimers Dement. 2009; 6(4): 303-311.
63. Heise V, Filippini N, Ebmeier KP, Mackay CE. The APOE varepsilon4 allele modulates brain white matter integrity in healthy adults. Mol. Psychiatr. 2010; 16(9): 908-916.
64. Smith CD, Chebrolu H, Andersen AH, Powell DA, Lovell MA, Xiong S, Gold BT. White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiol. Aging 2010; 31(7): 1122-1131.
65. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE. Differential effects of the APOE genotype on brain function across the lifespan. NeuroImage 2011; 54(1): 602-610.
66. Kukolja J, Thiel CM, Eggermann T, Zerres K, Fink GR. Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 2010; 168(2): 487-497.
67. Nierenberg J, Pomara N, Hoptman MJ, Sidtis JJ, Ardekani BA, Lim KO. Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers. NeuroReport 2005;16(12): 1369-1372.
68. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. NeuroImage 2003; 20(3): 1714-1722.
69. Tyszka JM, Readhead C, Bearer EL, Pautler RG, Jacobs RE. Statistical diffusion tensor histology reveals regional dysmyelination effects in the shiverer mouse mutant. NeuroImage 2006; 29(4): 1058-1065.
70. Zhang J, Jones M, DeBoy CA, Reich DS, Farrell JA, Hoffman PN, Griffin JW, Sheikh KA, Miller MI, Mori S, Calabresi PA. Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J. Neurosci. 2009; 29(10): 3160-3171.
71. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. NeuroImage 2002; 17(3): 1429-1436.
72. Bartzokis G, Lu PH, Geschwind DH, Tingus K, Huang D, Mendez MF, Edwards N, Mintz J. Apolipoprotein e affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol. Psychiat. 2007; 62(12): 1380-1387.
73. Budde MD, Kim JH, Liang HF, Russell JH, Cross AH, Song SK. Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed. 2008; 21(6): 589-597.
74. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, Mueller S, Du AT, Kramer JH, Yaffe K, Chui H, Jagust WJ, Miller BL, Weiner MW. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 2007; 68(1): 13-19.
75. Madden DJ, Bennett IJ, Song AW. Cerebral white matter integrity and cognitive aging: contributions from diffusion tensor imaging. Neuropsychol. Rev. 2009; 19(4): 415-435.
76. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002; 15(7-8): 435-455.
77. Metwalli NS, Benatar M, Nair G, Usher S, Hu XP, Carew JD. Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis. Brain Res. 2010; 1348: 156-164.
78. Della Nave R, Ginestroni A, Diciotti S, Salvatore E, Soricelli A, Mascalchi M. Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. Neuroradiology 2011; 53(5): 367-372.
79. Douaud G, Jbabdi S, Behrens TE, Menke RA, Gass A, Monsch AU, Rao A, Whitcher B, Kindlmann G, Matthews PM, Smith S. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. NeuroImage 2011; 55(3): 880-890.
80. Ridha BH, Tozer DJ, Symms MR, Stockton KC, Lewis EB, Siddique MM, MacManus DG, Rossor MN, Fox NC, Tofts PS. Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007; 244(3): 832-837.
81. Serra L, Cercignani M, Lenzi D, Perri R, Fadda L, Caltagirone C, Macaluso E, Bozzali M. Grey and white matter changes at different stages of Alzheimer's disease. J. Alzheimers Dis. 2010; 19(1): 147-159.